Project Description


CEO: Eric Milledge

Sector: Software
Location: California, USA
Investment Stage: Start up
Investment Status: Acquired by Covidien in 2013
Year Invested: 2010


Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. 

Nfocus Neuromedical was acquired by Covidien in 2013. 

See NFocus related news here

Back to all companies

Endeavour Vision
Deal Team

Damien Tappy

Damien Tappy